Avnish Deobhakta, MD
- ASSISTANT PROFESSOR | Ophthalmology
- Retina - Medical & Surgical
- Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Queens
- New York Eye and Ear Infirmary of Mount Sinai
- The Mount Sinai Hospital
Book an Appointment - Avnish Deobhakta, MD
Avnish Deobhakta, MD, completed his undergraduate studies at Stanford University and his medical degree from Weill Cornell Medical College. He subsequently completed his Ophthalmology residency at the Bascom Palmer Eye Institute at the University of Miami and then finished a 2-year surgical retina fellowship at Columbia University. Some of his research interests include experimental treatment modalities for Age Related Macular Degeneration, novel surgical techniques for Retinal Detachment and other surgical retinal diseases, and unique imaging techniques for retinal disease. Dr. Avnish Deobhakta is a member of the American Society of Retina Specialists and The American Academy of Ophthalmology.
Dr. Deobhakta's research and expertise have been featured in a variety of publications, including CNN, NPR, the Wall Street Journal, and NBC (shown below), as well as the LA Times, the Washington Post, WebMD, USA Today, among others.
The Wall Street Journal: https://www.wsj.com/articles/an-unfortunate-memento-of-the-total-eclipse-eye-damage-1512666000
NBC New York: https://www.nbcnewyork.com/on-air/as-seen-on/Some-Eclipse-Gazers-Report-Ill-Effects_New-York-441450883.html
- Diabetes Care - Eye Exam
- Diabetic Retinopathy
- Eye Emergency Visit
- Macular Degeneration
- Retinal Detachment
- Retinal Detachment Repair
- Retinal Vein / Artery Occlusion
- Retinitis Pigmentosa
BA, Stanford University
MD, New York Hospital/Cornell University Medical College
Internship, Internal Medicine
Beth Israel Deaconess Medical Center- Harvard Medical School
Bascom Palmer Eye Institute
Columbia University Medical Center
Alpha Omega Alpha Honor Society
Cornell University Medical College
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Deobhakta during 2019 and/or 2020. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- Alina Technologies LLC
Scientific Advisory Board:
- Alimera Sciences
- Allergan, Inc.
Service on Board of Directors: Service in a fiduciary capacity, such as an officer or director, for the following companies:
- Alina Technologies LLC
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.